Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
Ying Chen, Shuanglian Li, Chaline Brown et al. · Pharmacogenetics and Genomics · 2009
OBJECTIVE: The goal of this study was to determine the effect of a genetic variant in the organic cation transporter 2 (OCT2), OCT2-808G/T, which results in an amino acid change, A270S, on the pharmacokinetics of the antidiabetic drug, metformin. METHODS: The uptake of metformin was performed in stably transfected HEK-293 cells expressing the empty vector (MOCK), the reference OCT2-808G, and the variant OCT2-808T. Healthy individuals with known OCT2 genotypes [14 homozygous for the OCT2 reference allele (808G/G) and nine heterozygous for the variant allele (808G/T, *3D)] were recruited to this study. Metformin concentrations in plasma and urine were measured by liquid chromatography-tandem mass spectrometry method. Creatinine levels were also measured in plasma and urine. Pharmacokinetic parameters were evaluated for both the groups. RESULTS: We observed that in HEK-293 stably transfected cells, OCT2-808T had a greater capacity to transport metformin than did the reference OCT2. Metformin pharmacokinetics was characterized in 23 healthy volunteers of Caucasian and African-American ancestries. We observed that the renal clearance (CL(R)) and the net secretion (SrCL(R)) of metformin were significantly different between the volunteers heterozygous for the variant allele (808G/T), and the volunteers homozygous for the reference allele (808G/G) (P<0.005). Multivariate analysis revealed that OCT2 genotype was a significant predictor of CL(R) and SrCL(R) of metformin (P<0.01). CONCLUSION: We conclude that genetic variation in OCT2 plays an important role in the CL(R) and SrCL(R) of metformin in healthy volunteers.
Cited by 248 works. doi:10.1097/fpc.0b013e32832cc7e9
Authors
- Ying Chen
- Shuanglian Li
- Chaline Brown
- S. Christian Cheatham
- Richard A. Castro
- Maya K. Leabman
- Thomas Jacob Urban
- Ligong Chen
- Sook Wah Yee
- Ji Ha Choi
- Yong An Huang
- Claire M. Brett
- Esteban G. Burchard
- Kathleen M. Giacomini
References
- Metformin: An Update
- Metformin kinetics in healthy subjects and in patients with diabetes mellitus.
- Clinical Pharmacokinetics of Metformin
- Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled study
- Disposition of metformin (N,N‐dimethylbiguanide) in man
- A human transporter protein that mediates the final excretion step for toxic organic cations
- Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics
- Measurement of the renal clearance of drugs.
- Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function
- Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters